SAN DIEGO, Oct. 1, 2022 (GLOBE NEWSWIRE) — Robbins Geller Rudman & Dowd LLP announces that buyers of LifeStance Health Group, Inc. LFST Common shares issued in connection with LifeStance Health’s initial public offering on June 10, 2021 (the “IPO”) have until Tuesday, October 11, 2022 to file a motion for appointment as Lead Plaintiff attitude to life Healthcare Class Action. Filed and annotated by Robbins Geller Nayani v LifeStance Health Group, Inc.No. 22-cv-06833 (SDNY), the attitude to life Health’s class action lawsuit accuses LifeStance Health, certain of its top officers and directors, and the underwriters of the IPO of violating the Securities Act of 1933.
If you have suffered significant losses and wish to be a lead plaintiff, please provide your information here:
CASE CLAIMS: LifeStance Health is one of the nation’s largest providers of virtual and in-person outpatient mental health care. LifeStance Health benefited from the state and local lockdown measures necessitated by the COVID-19 pandemic beginning in Spring 2020. However, as of December 2020, multiple COVID-19 vaccines have been approved and administered, meaning LifeStance Health’s access to clients seeking virtual mental health services would decline significantly while demand for in-person services would increase. LifeStance Health completed its IPO on June 10, 2021, selling 46 million shares at $18.00 per share for gross proceeds of $828 million.
But as the LifeStance Health The class action alleges that the IPO’s registration statement failed to disclose the following material facts: (i) that the number of virtual visits customers made using LifeStance Health decreased as the COVID-19 lockdowns were lifted, causing LifeStance to flatten out…
Read full story here https://www.benzinga.com/pressreleases/22/10/g29109850/upcoming-lfst-investor-deadline-robbins-geller-rudman-dowd-llp-announces-that-lifestance-health-gr